Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Change in Intangibles (2020 - 2025)

Historic Change in Intangibles for Harvard Bioscience (HBIO) over the last 5 years, with Q3 2025 value amounting to $141000.0.

  • Harvard Bioscience's Change in Intangibles fell 3896.1% to $141000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $620000.0, marking a year-over-year decrease of 948.91%. This contributed to the annual value of $619000.0 for FY2024, which is 1835.56% up from last year.
  • Latest data reveals that Harvard Bioscience reported Change in Intangibles of $141000.0 as of Q3 2025, which was down 3896.1% from $144000.0 recorded in Q2 2025.
  • Over the past 5 years, Harvard Bioscience's Change in Intangibles peaked at $231000.0 during Q4 2023, and registered a low of $75000.0 during Q1 2024.
  • In the last 4 years, Harvard Bioscience's Change in Intangibles had a median value of $150000.0 in 2021 and averaged $158818.2.
  • Data for Harvard Bioscience's Change in Intangibles shows a peak YoY increase of 12666.67% (in 2025) and a maximum YoY decrease of 3896.1% (in 2025) over the last 5 years.
  • Over the past 4 years, Harvard Bioscience's Change in Intangibles (Quarter) stood at $150000.0 in 2021, then surged by 54.0% to $231000.0 in 2023, then dropped by 28.57% to $165000.0 in 2024, then fell by 14.55% to $141000.0 in 2025.
  • Its Change in Intangibles stands at $141000.0 for Q3 2025, versus $144000.0 for Q2 2025 and $170000.0 for Q1 2025.